Lacnotuzumab (MCS110) is a neutralizing humanized IgG1/kappa monoclonal antibody targeting CSF-1 that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis[1][2].
Molecular Weight:
(144.8 kDa)
Purity:
99.9
CAS Number:
[1831128-32-5]
Target:
c-Fms
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
